Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of HP-3060 (emedastine) patch in seasonal allergic rhinitis
jRCT2080223038Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of emedastine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
emedastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on jRCT2080223038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223038.